Elevation Oncology Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.
The company stated in the following report that they exploit animals for product testing.
“The OV-10-0050 PDX model was developed from an ovarian cancer specimen with a CLU-NRG1 fusion.Seribantumab at doses of 2.5 mg, 5 mg, and 10 mg BIW were tested. Near complete and complete tumor regressions were observed across the entire dose range, with complete tumor regressions observed in nearly all animals at the highest dose level of 10 mg BIW. Afatinib dosed at 5 mg/kg QD did not induce tumor regressions.” (Page 113) Read the full document
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. It focuses on identifying oncogenic drivers with other driver alterations and in the conduct of clinical trials.
Company Website: https://elevationoncology.com